Snapshot

Auto Refresh

$270.93

52-Week Range: $173.97 – $274.99
YTD: +30.43%
IV Rank (30D): 9.26
Straddle Price: $16.55

Info

First Trust NYSE Arca Biotechnology Index Fund (FBT) ETF

Exchange: ARCX
Inception: 2006-06-19
Has Options: Yes

ETF Profile

holdings as of 2026-12-31

Holdings

32

AUM

$2.3B

Provider

Nport

Inception

2006-06-19

Exchange

ARCX

Data As Of

2026-12-31

Expense Ratio

—

Dividend Yield

—

Distribution

Quarterly

Recent distributions

Ex-Date	Pay Date	Amount	Type
2024-12-13	2024-12-31	$1.1726	CD

Asset Allocation

Top Holdings

top 32 of 32 holdings

Symbol	Name	Weight %	Asset Class	Country
MRNA	Moderna Inc	5.26%	Equity (common)	US
UTHR	United Therapeutics Corporation	4.36%	Equity (common)	US
—	Alkermes PLC	4.24%	Equity (common)	IE
GILD	Gilead Sciences Inc.	4.09%	Equity (common)	US
AXSM	Axsome Therapeutics Inc.	3.89%	Equity (common)	US
AMGN	Amgen Inc.	3.83%	Equity (common)	US
CORT	Corcept Therapeutics Inc.	3.82%	Equity (common)	US
KRYS	Krystal Biotech Inc	3.51%	Equity (common)	US
BIIB	Biogen Inc	3.47%	Equity (common)	US
EXEL	Exelixis, Inc.	3.46%	Equity (common)	US
NBIX	Neurocrine Biosciences Inc	3.45%	Equity (common)	US
REGN	Regeneron Pharmaceuticals, Inc.	3.45%	Equity (common)	US
VRTX	Vertex Pharmaceuticals Incorporated	3.42%	Equity (common)	US
BMRN	Biomarin Pharmaceutical Inc.	3.40%	Equity (common)	US
ARGX	Argenx SE	3.29%	Equity (common)	NL
SRPT	Sarepta Therapeutics Inc	3.24%	Equity (common)	US
HALO	Halozyme Therapeutics Inc	3.17%	Equity (common)	US
BNTX	BioNTech SE	3.16%	Equity (common)	DE
INCY	Incyte Corporation.	3.13%	Equity (common)	US
ONC	BEONE MEDICINES LTD	3.12%	Equity (common)	CH
ILMN	Illumina Inc	3.10%	Equity (common)	US
NTRA	NATERA INC	3.03%	Equity (common)	US
ACAD	Acadia Pharmaceuticals Inc	2.95%	Equity (common)	US
ALNY	Alnylam Pharmaceuticals Inc.	2.95%	Equity (common)	US
TECH	Bio-Techne Corp	2.83%	Equity (common)	US
GMAB	Genmab As	2.78%	Equity (common)	DK
VCYT	Veracyte Inc	2.72%	Equity (common)	US
RGEN	Repligen Corporation	2.51%	Equity (common)	US
BRKR	Bruker Corporation	2.36%	Equity (common)	US
NEO	Neogenomics Inc	2.00%	Equity (common)	US
—	Dreyfus Government Cash Management Funds	0.06%	Short-term investment	US
—	DAIWA CAPITAL MARKETS AMERICA INC.	0.01%	Repurchase agreement	US

Geographic Breakdown

Summary

—

composite

—

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart

Seasonality

Month	Avg Return	Years of Data
Jan	+1.82%	6
Feb	-2.42%	6
Mar	+0.26%	6
Apr	-2.89%	6
May	+2.11%	6
Jun	+2.98%	6
Jul	+1.79%	6
Aug	+1.75%	6
Sep	-1.24%	6
Oct	+0.49%	5
Nov	+2.78%	5
Dec	+1.69%	5

Technical Indicators

? Indicator Guide

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators

SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
+DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.

Momentum Oscillators

RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility

Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
ATR / True Range — average daily $ move; sizing and stop-loss reference.
HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $266.32

SMA 50: $256.22

SMA 200: $221.69

Current: $270.93

EMA 12: $269.15

EMA 26: $263.69

MACD: 5.4554 | Signal: -0.2442

BULLISH

ADX (14): 32.69

TREND

+DI: 36.70

−DI: 19.85

Momentum Oscillators

RSI (14): 60.82

NEUTRAL

Stoch %K: 86.83

Stoch %D: 82.39

Williams %R: -27.14

Volume & Volatility

BB Upper: $278.93

BB Lower: $253.71

NEUTRAL

OBV: -4,044,193

Vol SMA 20: 44,619

Vol ROC: -44.31%

ATR: $4.26

True Range: $3.39

HV 20: 22.7%

HV 30: 23.2%

HV 60: 21.1%

Data Summary

Data Points: 500

Last Updated: Sep 4, 5:15 PM ET

Date Range: 2024-09-09T00:00:00 – 2026-09-04T00:00:00

AI Analysis

Here is my analysis of FBT, a biotech ETF:

Executive Summary

Overall assessment: NEUTRAL with confidence level 6/10.

Key drivers: Trend direction, momentum signals, and market context.

Primary risks: Volatility regime, beta interpretation, and options activity.

2-3 sentence investment thesis: FBT exhibits a neutral trend with mixed technical indicators. The stock's low volatility is an attractive feature, but the recent increase in IV rank suggests heightened risk. Earnings data availability would provide valuable insights into the ETF's performance.

Recent news sentiment impact: Positive news headlines have contributed to the stock's upward movement, with investors showing interest in the biotech sector.

Technical Analysis

Trend Direction:

Short-term (1-4 weeks): Uptrend
Medium-term (1-3 months): Neutral trend
Long-term (3-12 months): Uptrend

Support/Resistance Levels:

Upper Bollinger Band: $278.93
Middle line: $266.32
Lower Bollinger Band: $253.71

Momentum Signals:

RSI interpretation: 60.82 (neutral)
MACD signal: Bullish momentum (5.46 / Signal: -0.24 / Histogram: 5.70)
Bollinger Bands position: Neutral

Volume Analysis:

Volume SMA 20: 44619.08
On-Balance Volume (OBV): -4044193.80 (negative OBV suggests selling pressure)

News & Sentiment Analysis

Recent Headlines Summary:

The recent news headlines are mostly positive, with investors showing interest in the biotech sector and FBT's performance.

Sentiment Assessment: POSITIVE

Catalyst Identification: None notable

Market Narrative: The market narrative is aligned with the technical signals, indicating a neutral trend.

Risk & Volatility Assessment

Risk Interpretation:

Beta: 0.80 (vs SPY) - Low volatility
Alpha: 0.30 - Positive alpha suggests outperformance
Correlation: 0.47 - Moderate correlation with market

Volatility Regime:

Historical Volatility: HV20 22.7%, HV30 23.2%, HV60 21.1% (relatively low)
IV Premium vs HV30: 9.1% (positive = implied richer than realized)

Options Market Signals:

IV Rank: 9.3% (Low) - shows if volatility is historically high/low
Current IV: 25.3%
Expected Move: $16.55 (42 DTE), 7-DTE: $9.20

Downside Protection:

Support levels: Bollinger Bands, SMA 50, and previous lows
Risk management considerations: Stop-loss levels at key support levels

Market Context & Positioning

Sector Performance:

Biotech sector performance: Positive

Institutional Activity:

Volume patterns suggesting institutional interest: None notable

Correlation Analysis:

R-squared interpretation: FBT moves relatively independently of the market (0.47 correlation)

Relative Valuation:

Relative position within trading range: Neutral

Key Levels & Action Items

Critical Price Levels:

Support levels: Bollinger Bands, SMA 50, and previous lows
Resistance levels: Upper Bollinger Band ($278.93) and previous highs

Breakout/Breakdown Levels:

Technical levels that could trigger significant moves: None notable

Time-Sensitive Catalysts:

Earnings dates: None available

Risk Management:

Stop-loss levels at key support levels

Generated Sep 6, 12:15 PM ET

News

Filter Publishers:

Earnings History

Options Activity

IV Rank (30D): 9.26
IV Rank (7D): 37.9
Avg IV: 25.3%
Straddle (30D): $16.55
Straddle (7D): $9.20

Options Chain

Loading options chain...

Spread Scanner GPU

Auto Refresh

? Score Guide Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)

Group 1 · Directional Bias (±0.25)

RSI <40 bullish / >60 bearish
MACD crossover + histogram trend
Price vs SMA 50 & SMA 200

Group 2 · Momentum (±0.10)

Stochastic %K <20 / >80
Williams %R <−80 / >−20

Group 3 · Volatility (up to −0.25 / +0.15)

Blended ATR + straddle expected-move penalty
Bollinger Band signal (+ counter-trend penalty)
BB width — vol contraction boost for ICs

Group 4 · IV Regime (±0.15)

IV rank ≥ 75 → strong boost for credit spreads
IV rank < 25 → penalty (selling cheap vol)

Group 5 · Liquidity (penalty up to −0.10)

Min open interest across all legs
OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Dealer Positioning

—

Loading dealer positioning…

Skew (Wing IV − ATM IV)

DTE:

Wing Δ:

Metric:

? What do these mean

Wing vs ATM

IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.

Risk Reversal

IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.

Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.

14 DTE / 10d —

— pts

ATM — / Wing —

30 DTE / 10d —

— pts

ATM — / Wing —

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Skew Metrics per Expiry ? Guide

Risk Reversal (RR)

IV(10% OTM call) − IV(10% OTM put)

Measures the direction of skew — which side the market is paying up for. Expressed as a vol difference in percentage points.

−3% to −10% → mild to moderate put skew. Normal for most large-cap stocks — puts always carry some premium from portfolio hedging demand.
−10% to −20% → strong put skew. Elevated fear, heavy hedging, or an upcoming catalyst (earnings, macro event). Worth noting.
Below −20% → extreme put skew. Stress signal — market aggressively buying downside protection.
−3% to 0% → nearly symmetric. Rare for equities; means the market sees roughly equal up/down risk.
Positive → calls more expensive than puts. Unusual — signals strong upside momentum, short squeeze risk, or takeover speculation.

Butterfly (BF)

½ × (IV call + IV put) − IV ATM

Measures curvature — how much the wings are bid up relative to ATM. Always expressed as a positive number (wing premium). Think of it as the cost of a tail hedge above and beyond the ATM vol.

0% to 2% → flat smile. Market pricing near-normal return distribution, low tail risk.
2% to 5% → moderate wing premium. Some tail risk priced in — typical in earnings cycles or elevated VIX environments.
Above 5% → high curvature. Fat tails aggressively priced — market expects a large move but is uncertain of direction. Very common right before earnings.

Reading them together

RR	BF	Interpretation
-15%	+5%	Strong put skew + fat tails — fear or upcoming catalyst (earnings, FDA)
-5%	+1%	Normal mild put skew, calm market
-20%	+8%	Extreme fear — heavy hedging, major event risk
~0%	+2%	Balanced market, no strong directional bias
+5%	+3%	Call skew — bullish momentum or short squeeze risk

Expiry	DTE	ATM IV	25d Put IV	25d Call IV	Risk Reversal	Butterfly	Interpretation	Strategy Suggestions (hover for rationale)

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)

IV Rank (30 DTE)

Straddle Price (30 DTE)

Beta Analysis

Beta (1Y vs SPY): 0.80
Correlation (SPY): 47.1%
R²: 0.22
Ann. Volatility: 21.8%
SPY Volatility: 12.8%

Low volatility - stock moves less than market

Beta & Alpha Over Time

Institutional Ownership (13F)

Latest filings — 2026-06-30

? 13F Guide

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

Shares — long equity positions in this name, aggregated across share classes.
Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
% of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

350 filers8,074,853 shares$1.91B value

#	Filer	Shares	Value	% of Total	% of Float	Period
1	FIRST TRUST ADVISORS LP	3,388,725	$840.03M	43.88%	—	2026-06-30
2	MORGAN STANLEY Custodian	545,436	$135.21M	7.06%	—	2026-06-30
3	WELLS FARGO & COMPANY/MN Custodian	426,213	$85.59M	4.47%	—	2026-03-31
4	LPL Financial LLC Custodian	258,714	$64.13M	3.35%	—	2026-06-30
5	RAYMOND JAMES FINANCIAL INC Custodian	221,361	$54.87M	2.87%	—	2026-06-30
6	ROYAL BANK OF CANADA Custodian	210,355	$52.15M	2.72%	—	2026-06-30
7	BANK OF AMERICA CORP /DE/ Custodian	209,087	$51.83M	2.71%	—	2026-06-30
8	UBS Group AG Custodian	205,511	$50.94M	2.66%	—	2026-06-30
9	Berger Financial Group, Inc	102,351	$25.37M	1.33%	—	2026-06-30
10	Nilsine Partners, LLC	97,225	$24.10M	1.26%	—	2026-06-30
11	STIFEL FINANCIAL CORP Custodian	91,239	$22.62M	1.18%	—	2026-06-30
12	TWO SIGMA INVESTMENTS, LP Custodian	89,200	$22.11M	1.16%	—	2026-06-30
13	WCG Wealth Advisors LLC	83,489	$20.70M	1.08%	—	2026-06-30
14	&PARTNERS	77,150	$19.09M	1.00%	—	2026-06-30
15	Advisory Services Network, LLC Custodian	71,809	$17.80M	0.93%	—	2026-06-30
16	Summit Financial, LLC	66,638	$16.52M	0.86%	—	2026-06-30
17	NewEdge Advisors, LLC	66,409	$16.46M	0.86%	—	2026-06-30
18	ENVESTNET ASSET MANAGEMENT INC	62,403	$15.47M	0.81%	—	2026-06-30
19	TRUIST FINANCIAL CORP Custodian	56,835	$14.09M	0.74%	—	2026-06-30
20	OSAIC HOLDINGS, INC. Custodian	54,786	$13.58M	0.71%	—	2026-06-30
21	Csenge Advisory Group	49,202	$12.20M	0.64%	—	2026-06-30
22	NewSquare Capital LLC	49,037	$12.16M	0.64%	—	2026-06-30
23	Cetera Investment Advisers Custodian	48,515	$12.03M	0.63%	—	2026-06-30
24	D.A. DAVIDSON & CO.	47,983	$11.89M	0.62%	—	2026-06-30
25	TD Waterhouse Canada Inc.	47,342	$11.80M	0.62%	—	2026-06-30

4 filers$6.05M notional

#	Filer	Notional Value	% of Total	Period
1	SUSQUEHANNA INTERNATIONAL GROUP, LLP Custodian	$3.59M	59.43%	2026-06-30
2	JANE STREET GROUP, LLC Custodian	$1.09M	18.03%	2026-06-30
3	Belvedere Trading LLC	$718.88K	11.89%	2026-06-30
4	CITADEL ADVISORS LLC Custodian	$644.51K	10.66%	2026-06-30

1 filers$1.44M notional

#	Filer	Notional Value	% of Total	Period
1	Belvedere Trading LLC	$1.44M	100.00%	2026-06-30

Insider Activity

Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.

Filed	Reporter	Role	Action	Shares	Avg Price	Net $	Link

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

Notice of Proposed Sale (Form 144)

Recent SEC Filings

Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).

Filing Date	Accession	Link

Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.

Filing Date	Accession	Link

Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.

Filing Date	Accession	Link

ETF Holders

#	ETF	Provider	Weight	$ Exposure	ETF AUM	As Of

Fundamentals

? Fundamentals Guide

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics

Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.

How to read the bars

Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
YoY growth — compare to the same quarter a year earlier to remove seasonality.
Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Valuation

? Valuation Guide

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples

P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
EV/Sales — like P/S but accounts for debt + cash. Compare within sector.

Profitability & Yields

ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.

Balance Sheet

Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.

Reading the history chart

Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
Multiples expanding while earnings are flat = sentiment-driven rally.
Multiples compressing while earnings grow = value coming from fundamentals.

Metric:

Short Interest & Float

? Short Interest Guide

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions

Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
SI % of Float — short interest / free float. The key crowding metric.
Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
Free Float — shares available for public trading (total shares minus insider / restricted).
Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.

How to read the signals

SI % of Float < 5% — typical, no particular signal.
5–15% — elevated; watch for catalysts (earnings, guidance, macro).
15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
>30% — extreme; borrow is likely expensive and squeeze risk is material.
Days to Cover > 5 combined with high SI% amplifies squeeze potential.

History chart

Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Metric:

Constituent Performance

Select Timeframe:

Click any bar to view the full quote for that stock.

Constituents

Symbol	Name	Weight %	Price	1 Day	1 Week	1 Month

First Trust NYSE Arca Biotechnology Index Fund(FBT · ETF)

First Trust NYSE Arca Biotechnology Index Fund (FBT) ETF

Trend Indicators

Momentum Oscillators

Volume & Volatility

Data Summary

Executive Summary

Technical Analysis

News & Sentiment Analysis

Risk & Volatility Assessment

Market Context & Positioning

Key Levels & Action Items